Oral GLP-1 formulations are adding manufacturing complexity in a different dimension: on December 22, 2025, the FDA approved Novo Nordisk's oral Wegovy 25 mg as the first oral GLP-1 therapy for weight loss, bringing with it the manufacturing requirements of oral solid dosage pharmaceutical production at commercial scale, a fundamentally different infrastructure challenge from parenteral peptide API synthesis

Supplement Facts: Serving Size: 1 Bar (60g) Servings Per Container: 12 Amount Per Serving: Energy kcal: 214 kcal Energy kJ: 896 kJ Fat: 13.2 g of which saturates: 4.2 g Carbohydrates: 13.5 g of which sugars: 1.4 g of which polyols: 10.6 g Fibre: 6.7 g Protein: 23.2 g Salt: 0.45 g *RI - Reference Intake Ingredients: MILK Protein, MILK Chocolate (Sweetener: Maltitol, Cocoa Butter, Whole Milk Powder, Cocoa Mass, Emulsifier (SOY Lecithin), Flavours) 18.3%, Gelatine Hydrolysate, Bulking Agent (Polydextrose), Humectant (Glycerol), SOY Crisps (SOY Protein, Tapioca Starch, Salt), SOY Crisp (SOY Protein, Fat Reduced Cocoa, Tapioca Starch), Cocoa Butter, SOY Oil, Skimmed MILK Powder, Palm Fat, Sweeteners (Xylitol, Sucralose), Flavours, Fat Reduced Cocoa, Salt, Emulsifier (SOY Lecithin)
$5.95 $8.50 Wellness Fizz Tangerine $5.95 Wellness Formula Caps On Sale
Wang Y, et al
L-Carnitine (500mg): A key ingredient in energy production, helping your body convert fat stores into usable energy